Inspection Fees Face Tough Road In Congress As PhRMA Remains Opposed
Executive Summary
At user fee hearing, PhRMA’s Wheadon counters questions from Rep. Dingell, saying FDA already is receiving resources to conduct GMP inspections outside the U.S.
You may also be interested in...
FDA User Fee Bill Up For Final Senate Action After House Passage
Senate is last step before the bill goes to the president; Rep. Dingell laments that legislators were “closer than ever before” on a tracking agreement but did not quite make it.
GMP Carrots For Quality: FDA Considers Incentives To Adopt Quality Systems
The type of incentive remains under consideration, but one suggestion is a grading system similar to what restaurants receive from local health departments.
FDA Highlights Hands-On Approach To China Inspections In Budget Plan
The budget request targets an increase in pharmaceutical programs’ budget authority to boost the number of FDA staff focused on China’s manufacturing. The proposed $10 million increase, including $5.6 million to be allocated toward manufacturing, provides for additional inspections, educational efforts and inspectors in China.